NEOG Stock Analysis: Buy, Sell, or Hold?
NEOG - Neogen Corp
$11.95
0.12 (1.01%)
▲
5d:
+2.58%
30d:
+24.35%
90d:
+34.88%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 08, 2026
Get Alerted When NEOG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NEOG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NEOG shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.26
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$5.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEOG is currently trading at $11.95, which is considered extended relative to its 30-day fair value range of $9.83 to $11.85. From a valuation perspective, the stock is trading at a premium (Forward PE: 39.8) compared to its historical average (29.7). At these levels, the market is pricing in 10.3% annual earnings growth.
Technical Outlook: Technically, NEOG is in a uptrend. The price is approaching resistance at $12.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NEOG scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NEOG is in a uptrend. The price is approaching resistance at $12.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NEOG scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.83 -
$11.85
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding NEOG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($13.00)
- BULLISH: Expecting earnings turnaround to 10.3% growth with -0.1% revenue growth
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.83 -
$11.85
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.21
Resistance Level
$12.26
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
39.83
Wall Street Target
$13.00
(+8.8%)
Revenue Growth (YoY)
-0.1%
Earnings Growth (YoY)
-85.6%
Profit Margin
-0.9%
Valuation Premium vs History
+10.3% premium
PE vs Historical
39.8 vs 29.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.3%
(market-implied from PE analysis)
1-Year Target
$13.18
(+10%)
2-Year Target
$14.54
(+22%)
3-Year Target
$16.04
(+34%)
3-Yr Target (if PE normalizes)
(PE: 40→30)
PE COMPRESSION
$11.96
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 39.8, Growth: 4.6%)
$13.69
(+15%)
Base:
(SPY PE: 20.1, Growth: 4.6%)
$6.90
(-42%)
Bear:
(PE: 17.1, Growth: 4.6%)
$5.86
(-51%)
Share & Embed Analysis
Last updated: August 22, 2026 11:50 AM ET
Data refreshes hourly during market hours. Next update: 12:50 PM
Data refreshes hourly during market hours. Next update: 12:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEOG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
Advanced NEOG Option Strategies
Professional options setups generated by AI based on today's NEOG price and gamma walls.
